Patients | (n = 196) |
---|---|
Age (median, range) | 10,7 years (3,1–17,9 years) |
Female gender (%) | 141 (72 %) |
Disease duration (median, range) | 3,8 years (15,9-0,5 years) |
Duration of MTX treatment (median, range) | 1,2 years (13,2- 0,3 years) |
Patients with MTX intolerance (%) | 90 (45,9 %) |
Patients on folic acid | 184 (94 %) |
Patients on folic acid with MTX intolerance | 84 (93 %) |